1 completed, 1 recruiting, 1 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow trimodulin: new trials by email Literature Review of trimodulin trials Research Report on trimodulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) Trimodulin, Placebo (human albumin 1%) - Community-acquired Pneumonia | Phase 3 | Recruiting | Biotest | 590 | 2023-09-09 | 2026-09-14 |
| Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia Trimodulin, Placebo (human albumin 1%) - Respiratory Infection, Pneumonia | Phase 3 | Terminated | Biotest | 107 | 2022-12-22 | 2025-06-08 |
| Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 Trimodulin, Placebo (human albumin 1%) - Covid19 | Phase 2 | Completed | Biotest | 166 | 2020-10-06 | 2023-01-10 |
Community-Acquired Pneumonia (3) · COVID-19 (2) · Respiratory Distress Syndrome (2) · Pneumonia (1) · Pneumonia, Bacterial (1) · Pneumonia, Viral (1) · Respiratory Tract Infections (1)
Biotest (3)
Brazil (3) · France (3) · Spain (3) · Argentina (2) · Austria (2) · Belgium (2) · Germany (2) · Hungary (2) · South Africa (2) · Australia (1) · Czechia (1) · Ireland (1) · Israel (1) · Latvia (1) · Lithuania (1)
Antoni Torres, MD (1) · Antoni Torres, Prof (1) · Ricard Ferrer Roca, Dr. (1)